HIGHLIGHTS
- who: George R. Abraham from the Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK have published the research work: Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19, in the Journal: (JOURNAL)
- what: Our results demonstrate that elevated ET-1 in the acute phase of Covid-19 infection is a clinical feature unique to severe disease, supĀ porting the hypothesis [8] that endothelin receptor antagonists, used to Journal of Molecular and Cellular Cardiology 167 . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.